低密度リポタンパク質アフェレーシス療法のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Low-density Lipoprotein Apheresis Therapy Market Insights, Forecast to 2028

• レポートコード：QY2207E09671 • 出版社/出版日：QYResearch / 2022年7月 • レポート形態：英文、PDF、89ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界の低密度リポタンパク質アフェレーシス療法の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に低密度リポタンパク質アフェレーシス療法の世界市場のxxx％を占める「ダブルフィルトレーションLDLアフェレーシス療法」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「アテローム性動脈硬化症患者」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国の低密度リポタンパク質アフェレーシス療法の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの低密度リポタンパク質アフェレーシス療法市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの低密度リポタンパク質アフェレーシス療法市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 低密度リポタンパク質アフェレーシス療法のグローバル主要メーカーには、Kaneka Pharma、B.Braun、Fresenius Medical Care、Asahi Kasei Medical、Medicap、Kawasumi Laboratories、Terumo Corporation、Haemoneticsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 低密度リポタンパク質アフェレーシス療法市場は、種類と用途によって区分されます。世界の低密度リポタンパク質アフェレーシス療法市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 ダブルフィルトレーションLDLアフェレーシス療法、カスケードフィルトレーションLDLアフェレーシス療法 【用途別セグメント】 アテローム性動脈硬化症患者、肥満患者、脂質異常症患者、冠状動脈性心臓病患者、頸動脈疾患患者 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 低密度リポタンパク質アフェレーシス療法製品概要 - 種類別市場（ダブルフィルトレーションLDLアフェレーシス療法、カスケードフィルトレーションLDLアフェレーシス療法） - 用途別市場（アテローム性動脈硬化症患者、肥満患者、脂質異常症患者、冠状動脈性心臓病患者、頸動脈疾患患者） - 調査の目的 ・エグゼクティブサマリー - 世界の低密度リポタンパク質アフェレーシス療法販売量予測2017-2028 - 世界の低密度リポタンパク質アフェレーシス療法売上予測2017-2028 - 低密度リポタンパク質アフェレーシス療法の地域別販売量 - 低密度リポタンパク質アフェレーシス療法の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別低密度リポタンパク質アフェレーシス療法販売量 - 主要メーカー別低密度リポタンパク質アフェレーシス療法売上 - 主要メーカー別低密度リポタンパク質アフェレーシス療法価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（ダブルフィルトレーションLDLアフェレーシス療法、カスケードフィルトレーションLDLアフェレーシス療法） - 低密度リポタンパク質アフェレーシス療法の種類別販売量 - 低密度リポタンパク質アフェレーシス療法の種類別売上 - 低密度リポタンパク質アフェレーシス療法の種類別価格 ・用途別市場規模（アテローム性動脈硬化症患者、肥満患者、脂質異常症患者、冠状動脈性心臓病患者、頸動脈疾患患者） - 低密度リポタンパク質アフェレーシス療法の用途別販売量 - 低密度リポタンパク質アフェレーシス療法の用途別売上 - 低密度リポタンパク質アフェレーシス療法の用途別価格 ・北米市場 - 北米の低密度リポタンパク質アフェレーシス療法市場規模（種類別、用途別） - 主要国別の低密度リポタンパク質アフェレーシス療法市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの低密度リポタンパク質アフェレーシス療法市場規模（種類別、用途別） - 主要国別の低密度リポタンパク質アフェレーシス療法市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の低密度リポタンパク質アフェレーシス療法市場規模（種類別、用途別） - 主要国別の低密度リポタンパク質アフェレーシス療法市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の低密度リポタンパク質アフェレーシス療法市場規模（種類別、用途別） - 主要国別の低密度リポタンパク質アフェレーシス療法市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの低密度リポタンパク質アフェレーシス療法市場規模（種類別、用途別） - 主要国別の低密度リポタンパク質アフェレーシス療法市場規模（トルコ、サウジアラビア） ・企業情報 Kaneka Pharma、B.Braun、Fresenius Medical Care、Asahi Kasei Medical、Medicap、Kawasumi Laboratories、Terumo Corporation、Haemonetics ・産業チェーン及び販売チャネル分析 - 低密度リポタンパク質アフェレーシス療法の産業チェーン分析 - 低密度リポタンパク質アフェレーシス療法の原材料 - 低密度リポタンパク質アフェレーシス療法の生産プロセス - 低密度リポタンパク質アフェレーシス療法の販売及びマーケティング - 低密度リポタンパク質アフェレーシス療法の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 低密度リポタンパク質アフェレーシス療法の産業動向 - 低密度リポタンパク質アフェレーシス療法のマーケットドライバー - 低密度リポタンパク質アフェレーシス療法の課題 - 低密度リポタンパク質アフェレーシス療法の阻害要因 ・主な調査結果

Market Analysis and Insights: Global Low-density Lipoprotein Apheresis Therapy Market
The global Low-density Lipoprotein Apheresis Therapy market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Double Filtration LDL Apheresis Therapy accounting for % of the Low-density Lipoprotein Apheresis Therapy global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Atherosclerosis Patient segment is altered to an % CAGR throughout this forecast period.
China Low-density Lipoprotein Apheresis Therapy market size is valued at US$ million in 2021, while the North America and Europe Low-density Lipoprotein Apheresis Therapy are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Low-density Lipoprotein Apheresis Therapy landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Low-density Lipoprotein Apheresis Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Low-density Lipoprotein Apheresis Therapy market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Low-density Lipoprotein Apheresis Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Low-density Lipoprotein Apheresis Therapy market.
Global Low-density Lipoprotein Apheresis Therapy Scope and Market Size
Low-density Lipoprotein Apheresis Therapy market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Low-density Lipoprotein Apheresis Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Double Filtration LDL Apheresis Therapy
Cascade Filtration LDL Apheresis Therapy
Segment by Application
Atherosclerosis Patient
Obesity Patient
Dyslipidemia Patient
Coronary Heart Disease Patient
Carotid Artery Disease Patient
By Company
Kaneka Pharma
B.Braun
Fresenius Medical Care
Asahi Kasei Medical
Medicap
Kawasumi Laboratories
Terumo Corporation
Haemonetics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

レポート目次

---

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Low-density Lipoprotein Apheresis Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Double Filtration LDL Apheresis Therapy
1.2.3 Cascade Filtration LDL Apheresis Therapy
1.3 Market by Application
1.3.1 Global Low-density Lipoprotein Apheresis Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Atherosclerosis Patient
1.3.3 Obesity Patient
1.3.4 Dyslipidemia Patient
1.3.5 Coronary Heart Disease Patient
1.3.6 Carotid Artery Disease Patient
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Low-density Lipoprotein Apheresis Therapy Market Perspective (2017-2028)
2.2 Low-density Lipoprotein Apheresis Therapy Growth Trends by Region
2.2.1 Low-density Lipoprotein Apheresis Therapy Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Low-density Lipoprotein Apheresis Therapy Historic Market Size by Region (2017-2022)
2.2.3 Low-density Lipoprotein Apheresis Therapy Forecasted Market Size by Region (2023-2028)
2.3 Low-density Lipoprotein Apheresis Therapy Market Dynamics
2.3.1 Low-density Lipoprotein Apheresis Therapy Industry Trends
2.3.2 Low-density Lipoprotein Apheresis Therapy Market Drivers
2.3.3 Low-density Lipoprotein Apheresis Therapy Market Challenges
2.3.4 Low-density Lipoprotein Apheresis Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Low-density Lipoprotein Apheresis Therapy Players by Revenue
3.1.1 Global Top Low-density Lipoprotein Apheresis Therapy Players by Revenue (2017-2022)
3.1.2 Global Low-density Lipoprotein Apheresis Therapy Revenue Market Share by Players (2017-2022)
3.2 Global Low-density Lipoprotein Apheresis Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Low-density Lipoprotein Apheresis Therapy Revenue
3.4 Global Low-density Lipoprotein Apheresis Therapy Market Concentration Ratio
3.4.1 Global Low-density Lipoprotein Apheresis Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Low-density Lipoprotein Apheresis Therapy Revenue in 2021
3.5 Low-density Lipoprotein Apheresis Therapy Key Players Head office and Area Served
3.6 Key Players Low-density Lipoprotein Apheresis Therapy Product Solution and Service
3.7 Date of Enter into Low-density Lipoprotein Apheresis Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Low-density Lipoprotein Apheresis Therapy Breakdown Data by Type
4.1 Global Low-density Lipoprotein Apheresis Therapy Historic Market Size by Type (2017-2022)
4.2 Global Low-density Lipoprotein Apheresis Therapy Forecasted Market Size by Type (2023-2028)
5 Low-density Lipoprotein Apheresis Therapy Breakdown Data by Application
5.1 Global Low-density Lipoprotein Apheresis Therapy Historic Market Size by Application (2017-2022)
5.2 Global Low-density Lipoprotein Apheresis Therapy Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Low-density Lipoprotein Apheresis Therapy Market Size (2017-2028)
6.2 North America Low-density Lipoprotein Apheresis Therapy Market Size by Type
6.2.1 North America Low-density Lipoprotein Apheresis Therapy Market Size by Type (2017-2022)
6.2.2 North America Low-density Lipoprotein Apheresis Therapy Market Size by Type (2023-2028)
6.2.3 North America Low-density Lipoprotein Apheresis Therapy Market Share by Type (2017-2028)
6.3 North America Low-density Lipoprotein Apheresis Therapy Market Size by Application
6.3.1 North America Low-density Lipoprotein Apheresis Therapy Market Size by Application (2017-2022)
6.3.2 North America Low-density Lipoprotein Apheresis Therapy Market Size by Application (2023-2028)
6.3.3 North America Low-density Lipoprotein Apheresis Therapy Market Share by Application (2017-2028)
6.4 North America Low-density Lipoprotein Apheresis Therapy Market Size by Country
6.4.1 North America Low-density Lipoprotein Apheresis Therapy Market Size by Country (2017-2022)
6.4.2 North America Low-density Lipoprotein Apheresis Therapy Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Low-density Lipoprotein Apheresis Therapy Market Size (2017-2028)
7.2 Europe Low-density Lipoprotein Apheresis Therapy Market Size by Type
7.2.1 Europe Low-density Lipoprotein Apheresis Therapy Market Size by Type (2017-2022)
7.2.2 Europe Low-density Lipoprotein Apheresis Therapy Market Size by Type (2023-2028)
7.2.3 Europe Low-density Lipoprotein Apheresis Therapy Market Share by Type (2017-2028)
7.3 Europe Low-density Lipoprotein Apheresis Therapy Market Size by Application
7.3.1 Europe Low-density Lipoprotein Apheresis Therapy Market Size by Application (2017-2022)
7.3.2 Europe Low-density Lipoprotein Apheresis Therapy Market Size by Application (2023-2028)
7.3.3 Europe Low-density Lipoprotein Apheresis Therapy Market Share by Application (2017-2028)
7.4 Europe Low-density Lipoprotein Apheresis Therapy Market Size by Country
7.4.1 Europe Low-density Lipoprotein Apheresis Therapy Market Size by Country (2017-2022)
7.4.2 Europe Low-density Lipoprotein Apheresis Therapy Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Low-density Lipoprotein Apheresis Therapy Market Size (2017-2028)
8.2 Asia-Pacific Low-density Lipoprotein Apheresis Therapy Market Size by Type
8.2.1 Asia-Pacific Low-density Lipoprotein Apheresis Therapy Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Low-density Lipoprotein Apheresis Therapy Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Low-density Lipoprotein Apheresis Therapy Market Share by Type (2017-2028)
8.3 Asia-Pacific Low-density Lipoprotein Apheresis Therapy Market Size by Application
8.3.1 Asia-Pacific Low-density Lipoprotein Apheresis Therapy Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Low-density Lipoprotein Apheresis Therapy Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Low-density Lipoprotein Apheresis Therapy Market Share by Application (2017-2028)
8.4 Asia-Pacific Low-density Lipoprotein Apheresis Therapy Market Size by Region
8.4.1 Asia-Pacific Low-density Lipoprotein Apheresis Therapy Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Low-density Lipoprotein Apheresis Therapy Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Low-density Lipoprotein Apheresis Therapy Market Size (2017-2028)
9.2 Latin America Low-density Lipoprotein Apheresis Therapy Market Size by Type
9.2.1 Latin America Low-density Lipoprotein Apheresis Therapy Market Size by Type (2017-2022)
9.2.2 Latin America Low-density Lipoprotein Apheresis Therapy Market Size by Type (2023-2028)
9.2.3 Latin America Low-density Lipoprotein Apheresis Therapy Market Share by Type (2017-2028)
9.3 Latin America Low-density Lipoprotein Apheresis Therapy Market Size by Application
9.3.1 Latin America Low-density Lipoprotein Apheresis Therapy Market Size by Application (2017-2022)
9.3.2 Latin America Low-density Lipoprotein Apheresis Therapy Market Size by Application (2023-2028)
9.3.3 Latin America Low-density Lipoprotein Apheresis Therapy Market Share by Application (2017-2028)
9.4 Latin America Low-density Lipoprotein Apheresis Therapy Market Size by Country
9.4.1 Latin America Low-density Lipoprotein Apheresis Therapy Market Size by Country (2017-2022)
9.4.2 Latin America Low-density Lipoprotein Apheresis Therapy Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Low-density Lipoprotein Apheresis Therapy Market Size (2017-2028)
10.2 Middle East & Africa Low-density Lipoprotein Apheresis Therapy Market Size by Type
10.2.1 Middle East & Africa Low-density Lipoprotein Apheresis Therapy Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Low-density Lipoprotein Apheresis Therapy Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Low-density Lipoprotein Apheresis Therapy Market Share by Type (2017-2028)
10.3 Middle East & Africa Low-density Lipoprotein Apheresis Therapy Market Size by Application
10.3.1 Middle East & Africa Low-density Lipoprotein Apheresis Therapy Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Low-density Lipoprotein Apheresis Therapy Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Low-density Lipoprotein Apheresis Therapy Market Share by Application (2017-2028)
10.4 Middle East & Africa Low-density Lipoprotein Apheresis Therapy Market Size by Country
10.4.1 Middle East & Africa Low-density Lipoprotein Apheresis Therapy Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Low-density Lipoprotein Apheresis Therapy Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Kaneka Pharma
11.1.1 Kaneka Pharma Company Details
11.1.2 Kaneka Pharma Business Overview
11.1.3 Kaneka Pharma Low-density Lipoprotein Apheresis Therapy Introduction
11.1.4 Kaneka Pharma Revenue in Low-density Lipoprotein Apheresis Therapy Business (2017-2022)
11.1.5 Kaneka Pharma Recent Developments
11.2 B.Braun
11.2.1 B.Braun Company Details
11.2.2 B.Braun Business Overview
11.2.3 B.Braun Low-density Lipoprotein Apheresis Therapy Introduction
11.2.4 B.Braun Revenue in Low-density Lipoprotein Apheresis Therapy Business (2017-2022)
11.2.5 B.Braun Recent Developments
11.3 Fresenius Medical Care
11.3.1 Fresenius Medical Care Company Details
11.3.2 Fresenius Medical Care Business Overview
11.3.3 Fresenius Medical Care Low-density Lipoprotein Apheresis Therapy Introduction
11.3.4 Fresenius Medical Care Revenue in Low-density Lipoprotein Apheresis Therapy Business (2017-2022)
11.3.5 Fresenius Medical Care Recent Developments
11.4 Asahi Kasei Medical
11.4.1 Asahi Kasei Medical Company Details
11.4.2 Asahi Kasei Medical Business Overview
11.4.3 Asahi Kasei Medical Low-density Lipoprotein Apheresis Therapy Introduction
11.4.4 Asahi Kasei Medical Revenue in Low-density Lipoprotein Apheresis Therapy Business (2017-2022)
11.4.5 Asahi Kasei Medical Recent Developments
11.5 Medicap
11.5.1 Medicap Company Details
11.5.2 Medicap Business Overview
11.5.3 Medicap Low-density Lipoprotein Apheresis Therapy Introduction
11.5.4 Medicap Revenue in Low-density Lipoprotein Apheresis Therapy Business (2017-2022)
11.5.5 Medicap Recent Developments
11.6 Kawasumi Laboratories
11.6.1 Kawasumi Laboratories Company Details
11.6.2 Kawasumi Laboratories Business Overview
11.6.3 Kawasumi Laboratories Low-density Lipoprotein Apheresis Therapy Introduction
11.6.4 Kawasumi Laboratories Revenue in Low-density Lipoprotein Apheresis Therapy Business (2017-2022)
11.6.5 Kawasumi Laboratories Recent Developments
11.7 Terumo Corporation
11.7.1 Terumo Corporation Company Details
11.7.2 Terumo Corporation Business Overview
11.7.3 Terumo Corporation Low-density Lipoprotein Apheresis Therapy Introduction
11.7.4 Terumo Corporation Revenue in Low-density Lipoprotein Apheresis Therapy Business (2017-2022)
11.7.5 Terumo Corporation Recent Developments
11.8 Haemonetics
11.8.1 Haemonetics Company Details
11.8.2 Haemonetics Business Overview
11.8.3 Haemonetics Low-density Lipoprotein Apheresis Therapy Introduction
11.8.4 Haemonetics Revenue in Low-density Lipoprotein Apheresis Therapy Business (2017-2022)
11.8.5 Haemonetics Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Low-density Lipoprotein Apheresis Therapy Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Double Filtration LDL Apheresis Therapy
Table 3. Key Players of Cascade Filtration LDL Apheresis Therapy
Table 4. Global Low-density Lipoprotein Apheresis Therapy Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Low-density Lipoprotein Apheresis Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Low-density Lipoprotein Apheresis Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Low-density Lipoprotein Apheresis Therapy Market Share by Region (2017-2022)
Table 8. Global Low-density Lipoprotein Apheresis Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Low-density Lipoprotein Apheresis Therapy Market Share by Region (2023-2028)
Table 10. Low-density Lipoprotein Apheresis Therapy Market Trends
Table 11. Low-density Lipoprotein Apheresis Therapy Market Drivers
Table 12. Low-density Lipoprotein Apheresis Therapy Market Challenges
Table 13. Low-density Lipoprotein Apheresis Therapy Market Restraints
Table 14. Global Low-density Lipoprotein Apheresis Therapy Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Low-density Lipoprotein Apheresis Therapy Revenue Share by Players (2017-2022)
Table 16. Global Top Low-density Lipoprotein Apheresis Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Low-density Lipoprotein Apheresis Therapy as of 2021)
Table 17. Ranking of Global Top Low-density Lipoprotein Apheresis Therapy Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Low-density Lipoprotein Apheresis Therapy Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Low-density Lipoprotein Apheresis Therapy Product Solution and Service
Table 21. Date of Enter into Low-density Lipoprotein Apheresis Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Low-density Lipoprotein Apheresis Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Low-density Lipoprotein Apheresis Therapy Revenue Market Share by Type (2017-2022)
Table 25. Global Low-density Lipoprotein Apheresis Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Low-density Lipoprotein Apheresis Therapy Revenue Market Share by Type (2023-2028)
Table 27. Global Low-density Lipoprotein Apheresis Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Low-density Lipoprotein Apheresis Therapy Revenue Share by Application (2017-2022)
Table 29. Global Low-density Lipoprotein Apheresis Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Low-density Lipoprotein Apheresis Therapy Revenue Share by Application (2023-2028)
Table 31. North America Low-density Lipoprotein Apheresis Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Low-density Lipoprotein Apheresis Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Low-density Lipoprotein Apheresis Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Low-density Lipoprotein Apheresis Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Low-density Lipoprotein Apheresis Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Low-density Lipoprotein Apheresis Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Low-density Lipoprotein Apheresis Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Low-density Lipoprotein Apheresis Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Low-density Lipoprotein Apheresis Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Low-density Lipoprotein Apheresis Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Low-density Lipoprotein Apheresis Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Low-density Lipoprotein Apheresis Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Low-density Lipoprotein Apheresis Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Low-density Lipoprotein Apheresis Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Low-density Lipoprotein Apheresis Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Low-density Lipoprotein Apheresis Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Low-density Lipoprotein Apheresis Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Low-density Lipoprotein Apheresis Therapy Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Low-density Lipoprotein Apheresis Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Low-density Lipoprotein Apheresis Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Low-density Lipoprotein Apheresis Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Low-density Lipoprotein Apheresis Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Low-density Lipoprotein Apheresis Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Low-density Lipoprotein Apheresis Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Low-density Lipoprotein Apheresis Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Low-density Lipoprotein Apheresis Therapy Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Low-density Lipoprotein Apheresis Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Low-density Lipoprotein Apheresis Therapy Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Low-density Lipoprotein Apheresis Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Low-density Lipoprotein Apheresis Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 61. Kaneka Pharma Company Details
Table 62. Kaneka Pharma Business Overview
Table 63. Kaneka Pharma Low-density Lipoprotein Apheresis Therapy Product
Table 64. Kaneka Pharma Revenue in Low-density Lipoprotein Apheresis Therapy Business (2017-2022) & (US$ Million)
Table 65. Kaneka Pharma Recent Developments
Table 66. B.Braun Company Details
Table 67. B.Braun Business Overview
Table 68. B.Braun Low-density Lipoprotein Apheresis Therapy Product
Table 69. B.Braun Revenue in Low-density Lipoprotein Apheresis Therapy Business (2017-2022) & (US$ Million)
Table 70. B.Braun Recent Developments
Table 71. Fresenius Medical Care Company Details
Table 72. Fresenius Medical Care Business Overview
Table 73. Fresenius Medical Care Low-density Lipoprotein Apheresis Therapy Product
Table 74. Fresenius Medical Care Revenue in Low-density Lipoprotein Apheresis Therapy Business (2017-2022) & (US$ Million)
Table 75. Fresenius Medical Care Recent Developments
Table 76. Asahi Kasei Medical Company Details
Table 77. Asahi Kasei Medical Business Overview
Table 78. Asahi Kasei Medical Low-density Lipoprotein Apheresis Therapy Product
Table 79. Asahi Kasei Medical Revenue in Low-density Lipoprotein Apheresis Therapy Business (2017-2022) & (US$ Million)
Table 80. Asahi Kasei Medical Recent Developments
Table 81. Medicap Company Details
Table 82. Medicap Business Overview
Table 83. Medicap Low-density Lipoprotein Apheresis Therapy Product
Table 84. Medicap Revenue in Low-density Lipoprotein Apheresis Therapy Business (2017-2022) & (US$ Million)
Table 85. Medicap Recent Developments
Table 86. Kawasumi Laboratories Company Details
Table 87. Kawasumi Laboratories Business Overview
Table 88. Kawasumi Laboratories Low-density Lipoprotein Apheresis Therapy Product
Table 89. Kawasumi Laboratories Revenue in Low-density Lipoprotein Apheresis Therapy Business (2017-2022) & (US$ Million)
Table 90. Kawasumi Laboratories Recent Developments
Table 91. Terumo Corporation Company Details
Table 92. Terumo Corporation Business Overview
Table 93. Terumo Corporation Low-density Lipoprotein Apheresis Therapy Product
Table 94. Terumo Corporation Revenue in Low-density Lipoprotein Apheresis Therapy Business (2017-2022) & (US$ Million)
Table 95. Terumo Corporation Recent Developments
Table 96. Haemonetics Company Details
Table 97. Haemonetics Business Overview
Table 98. Haemonetics Low-density Lipoprotein Apheresis Therapy Product
Table 99. Haemonetics Revenue in Low-density Lipoprotein Apheresis Therapy Business (2017-2022) & (US$ Million)
Table 100. Haemonetics Recent Developments
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Low-density Lipoprotein Apheresis Therapy Market Share by Type: 2021 VS 2028
Figure 2. Double Filtration LDL Apheresis Therapy Features
Figure 3. Cascade Filtration LDL Apheresis Therapy Features
Figure 4. Global Low-density Lipoprotein Apheresis Therapy Market Share by Application: 2021 VS 2028
Figure 5. Atherosclerosis Patient Case Studies
Figure 6. Obesity Patient Case Studies
Figure 7. Dyslipidemia Patient Case Studies
Figure 8. Coronary Heart Disease Patient Case Studies
Figure 9. Carotid Artery Disease Patient Case Studies
Figure 10. Low-density Lipoprotein Apheresis Therapy Report Years Considered
Figure 11. Global Low-density Lipoprotein Apheresis Therapy Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Low-density Lipoprotein Apheresis Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Low-density Lipoprotein Apheresis Therapy Market Share by Region: 2021 VS 2028
Figure 14. Global Low-density Lipoprotein Apheresis Therapy Market Share by Players in 2021
Figure 15. Global Top Low-density Lipoprotein Apheresis Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Low-density Lipoprotein Apheresis Therapy as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Low-density Lipoprotein Apheresis Therapy Revenue in 2021
Figure 17. North America Low-density Lipoprotein Apheresis Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America Low-density Lipoprotein Apheresis Therapy Market Size Market Share by Type (2017-2028)
Figure 19. North America Low-density Lipoprotein Apheresis Therapy Market Size Market Share by Application (2017-2028)
Figure 20. North America Low-density Lipoprotein Apheresis Therapy Market Size Share by Country (2017-2028)
Figure 21. United States Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Low-density Lipoprotein Apheresis Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe Low-density Lipoprotein Apheresis Therapy Market Size Market Share by Type (2017-2028)
Figure 25. Europe Low-density Lipoprotein Apheresis Therapy Market Size Market Share by Application (2017-2028)
Figure 26. Europe Low-density Lipoprotein Apheresis Therapy Market Size Share by Country (2017-2028)
Figure 27. Germany Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Low-density Lipoprotein Apheresis Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Low-density Lipoprotein Apheresis Therapy Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific Low-density Lipoprotein Apheresis Therapy Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific Low-density Lipoprotein Apheresis Therapy Market Size Share by Region (2017-2028)
Figure 37. China Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 43. Latin America Low-density Lipoprotein Apheresis Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America Low-density Lipoprotein Apheresis Therapy Market Size Market Share by Type (2017-2028)
Figure 45. Latin America Low-density Lipoprotein Apheresis Therapy Market Size Market Share by Application (2017-2028)
Figure 46. Latin America Low-density Lipoprotein Apheresis Therapy Market Size Share by Country (2017-2028)
Figure 47. Mexico Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Low-density Lipoprotein Apheresis Therapy Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa Low-density Lipoprotein Apheresis Therapy Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa Low-density Lipoprotein Apheresis Therapy Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa Low-density Lipoprotein Apheresis Therapy Market Size Share by Country (2017-2028)
Figure 53. Turkey Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE Low-density Lipoprotein Apheresis Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Kaneka Pharma Revenue Growth Rate in Low-density Lipoprotein Apheresis Therapy Business (2017-2022)
Figure 57. B.Braun Revenue Growth Rate in Low-density Lipoprotein Apheresis Therapy Business (2017-2022)
Figure 58. Fresenius Medical Care Revenue Growth Rate in Low-density Lipoprotein Apheresis Therapy Business (2017-2022)
Figure 59. Asahi Kasei Medical Revenue Growth Rate in Low-density Lipoprotein Apheresis Therapy Business (2017-2022)
Figure 60. Medicap Revenue Growth Rate in Low-density Lipoprotein Apheresis Therapy Business (2017-2022)
Figure 61. Kawasumi Laboratories Revenue Growth Rate in Low-density Lipoprotein Apheresis Therapy Business (2017-2022)
Figure 62. Terumo Corporation Revenue Growth Rate in Low-density Lipoprotein Apheresis Therapy Business (2017-2022)
Figure 63. Haemonetics Revenue Growth Rate in Low-density Lipoprotein Apheresis Therapy Business (2017-2022)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

---